GlassScriptPhysician profile
Nicole M Hook
NPI 1750379590
$2,331.52
in general payments reported to CMS, 2019-2025
27 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $191 · 2021: $546 · 2022: $201 · 2023: $343 · 2024: $401 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $332.28 | 2022-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Boston Scientific Corporation | $326.93 | 2021-2024 | Solyx Sis System |
| Abbvie INC. | $225.47 | 2019-2023 | |
| Coopersurgical, INC. | $208.14 | 2023-2024 | Supercut Hysterectomy Scissors, Paragard T 380a |
| Sumitomo Pharma America, INC. | $181.52 | 2023-2025 | Myfembree |
| Allergan, INC. | $132.81 | 2019-2020 | |
| Therapeuticsmd, INC. | $122.67 | 2019-2022 | |
| Astellas Pharma US INC | $111.12 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $80.42 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.35 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $66.53 | 2022-2024 | |
| Avion Pharmaceuticals | $52.90 | 2020-2021 | |
| Pfizer INC. | $49.60 | 2019-2023 | |
| Aspira Women'S Health INC | $44.81 | 2019-2021 | |
| Organon LLC | $43.41 | 2025 | Nexplanon |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $41.99 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $32.71 | 2019-2024 | Gardasil, Gardasil 9 |
| Momentis Surgical INC. | $30.00 | 2022 | |
| Evofem Biosciences, INC. | $26.00 | 2021 | |
| Becton, Dickinson and Company | $25.37 | 2024 | Bd Onclarity |
| Convatec INC. | $25.07 | 2021 | |
| Agile Therapeutics, INC. | $21.12 | 2021 | |
| Millicent US INC | $19.99 | 2020 | |
| Intuitive Surgical, INC. | $16.20 | 2019 | |
| Daiichi Sankyo INC. | $13.47 | 2021 | |
| Lupin INC. | $12.61 | 2019 | |
| Trevena, INC. | $12.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Hook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.